Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

609 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Completed

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

NCT01928459

Conditions
Acrocephalosyndactylia, Advanced Solid Tumors, Bone Diseases, +18 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Karmanos Cancer Institute Dept of Onc Detroit, Michigan, United States
  • Washington University School of Medicine Onc Dept St Louis, Missouri, United States
View all 22 locations
View Trial Details
Completed

A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer

NCT00620594

Conditions
Advanced Solid Tumors, Breast Cancer, Breast Diseases, +12 more
Locations
  • University of California at Los Angeles JonssonComprehensiveCancerCtr Los Angeles, California, United States
  • Yale University School of Medicine YaleCancerCtr-ClinTrialsOffice New Haven, Connecticut, United States
  • Dana Farber Cancer Institute Clinical Trials ProjectManager Boston, Massachusetts, United States
  • Nevada Cancer Institute NVCC - Huntsman Las Vegas, Nevada, United States
View all 15 locations
View Trial Details
Completed

Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors

NCT00426582

Conditions
Advanced Solid Tumors, Neoplasms
Locations
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Associates in Oncology Rockville, Maryland, United States
  • Wertz Clinical Cancer Center (Wayne State University) Detroit, Michigan, United States
  • Siteman Cancer Center (Washington University School of Medicine) St Louis, Missouri, United States
View Trial Details
Completed

First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation

NCT04006301

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • H. Lee Moffitt Cancer & Research Institute Tampa, Florida, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • NEXT Oncology San Antonio, Texas, United States
View Trial Details
Completed

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

NCT01363232

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +23 more
Locations
  • Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States
  • Karmanos Cancer Institute Study Coordinator Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center MSKCC (2) New York, United States
  • Cancer Centers of the Carolinas CCC Faris Greenville, South Carolina, United States
View Trial Details
Completed

MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations

NCT01352273

Conditions
Advanced Solid Tumors
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • Oregon Health & Science University OHSU 3 Portland, Oregon, United States
  • University of Utah / Huntsman Cancer Institute Huntman 2 Salt Lake City, Utah, United States
  • Pfizer Investigative Site Edmonton, Alberta, Canada
View Trial Details

Related conditions